Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis
Clinical trial NCT01904409 · COMPLETED
Trial details
- NCT number
- NCT01904409
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-06-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.